Outreach Signals
Publishing Details
About This Podcast
Podcasting 2.0 Features
Social Media
Explore Statistics
Recent Episodes
Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous
We love to hear from our listeners. Send us a message.In episode 123 of Cell & Gene: The Podcast, Host Erin Harris talks to Dr. Panteli Theocharous, FIBMS, M.S., Ph.D., FRCPath, about the patient…
Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness
We love to hear from our listeners. Send us a message.In episode 122 of Cell & Gene: The Podcast, Host Erin Harris talks to Paul Romness, CEO of OS Therapies, to learn the company’s mission to…
Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes
We love to hear from our listeners. Send us a message.In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO and Co-Founder Benjamin Oakes about building…
Advancing Off-the-Shelf CRISPR CAR-T Therapies into the Community Setting with Caribou Biosciences' Rachel Haurwitz
We love to hear from our listeners. Send us a message.Welcome to episode 120 of Cell & Gene: The Podcast. Host Erin Harris is joined by Rachel Haurwitz, CEO of Caribou Biosciences, to discuss the…
The Editors' Roundtable: A 2025 Retrospective of the Life Science Industry
We love to hear from our listeners. Send us a message.We’re sharing this Better Biopharma episode on Cell & Gene: The Podcast because Better Biopharma is a sister show in the Life Science Connect…
Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki
We love to hear from our listeners. Send us a message.In episode 119 of Cell & Gene The Podcast, Host Erin Harris talks to Dr. Norman Putzki, Global Head Clinical Development, Novartis, about the…
Turning the Tumor Microenvironment Against Cancer with MGB's Alexander Cryer, Ph.D.
We love to hear from our listeners. Send us a message.In Episode 118, Host Erin Harris talks to Alexander Cryer, Ph.D., Instructor in Medicine at Mass General Brigham, about a proof of concept…
Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault
We love to hear from our listeners. Send us a message.On episode 117, Host Erin Harris welcomes Paul Perreault, Strategic Advisor, Board Member and former CEO of CSL, who shares insights from his…
Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay
We love to hear from our listeners. Send us a message.In episode 116 of Cell & Gene: The Podcast, Host Erin Harris talks to Dr. Arun Upadhyay, Chief Scientific officer, Head of Research and…
Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer
We love to hear from our listeners. Send us a message.Episode 115 of Cell & Gene: The Podcast features Host Erin Harris' talk with Aliya Omer, Vice President and Global Head of Hematology and…
Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley
We love to hear from our listeners. Send us a message.On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell…
How AI and ML Drive iPSC Quality with Aspen Neuroscience's Thorsten Gorba, Ph.D.
We love to hear from our listeners. Send us a message.Welcome to Episode 113 of Cell & Gene: The Podcast. Host Erin Harris is joined by Thorsten Gorba, Ph.D., VP Process Development at Aspen…
Inside Sanofi’s Genomic Medicine Vision with Mike Quigley, Ph.D.
We love to hear from our listeners. Send us a message.On episode 112 of Cell & Gene: The Podcast, Michael Quigley, Ph.D., Chief Scientific Officer and Global Head of Research at Sanofi talks to…
Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther
We love to hear from our listeners. Send us a message.On episode 111 of Cell & Gene: The Podcast, Host Erin Harris talks to Ernexa Therapeutics' President and CEO, Sanjeev Luther, about how the…
What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago
We love to hear from our listeners. Send us a message.This is Episode 4 of "FDA Fridays," a special series from Cell & Gene: The Podcast, Chief Editor Erin Harris speaks with regulatory affairs…
Inside CRISPR-GPT with Yuanhao Qu
We love to hear from our listeners. Send us a message.In this episode of Cell & Gene Podcast episode, Host Erin Harris talks to Stanford School of Medicine Ph.D. student, Yuanhao Qu, about his…
Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.
We love to hear from our listeners. Send us a message.This is Episode 3 of "FDA Fridays," a 4-week special series from Cell & Gene: The Podcast. Host Erin Harris talks to Bambi Grilley, Ph.D.,…
Defining Product Roles and Navigating FDA Approval with Monika Swietlicka
We love to hear from our listeners. Send us a message.Episode 2 of FDA Fridays, the special series from Cell & Gene: The Podcast, features Host Erin Harris' discussion with regulatory expert…
Advancing Gene Therapy for FTD with Passage Bio's Dr. Will Chou
We love to hear from our listeners. Send us a message.In Episode 109 of Cell & Gene: The Podcast, Host Erin Harris talks to Will Chou, M.D., CEO of Passage Bio about the promise and challenges of…
FDA Fridays: Advancing Communication and Consistency in CGT Regulation with Kaye Spratt
We love to hear from our listeners. Send us a message.This is Episode 1 of a special series of Cell & Gene: The Podcast, "FDA Fridays." This first episode features Host, Erin Harris' conversation…
Frequently Asked Questions
Cell & Gene: The Podcast has published 129 episodes since June 2021, covering topics in Life Sciences, Science.
Cell & Gene: The Podcast is currently highly active with new episodes every 2 weeks. Average episode length is 25m.
